These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28879963)

  • 21. Human exposure, biomarkers, and fate of organotins in the environment.
    Okoro HK; Fatoki OS; Adekola FA; Ximba BJ; Snyman RG; Opeolu B
    Rev Environ Contam Toxicol; 2011; 213():27-54. PubMed ID: 21541847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of tributyltin to tin in freshwater river-bed sediments contaminated by an organotin release.
    Landmeyer JE; Tanner TL; Watt BE
    Environ Sci Technol; 2004 Aug; 38(15):4106-12. PubMed ID: 15352448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Consideration in Designing Organotin Polyethers to Arrest the Growth of Breast Cancer Cells In Vitro.
    Carraher CE; Roner MR; Shahi K; Barot G
    Materials (Basel); 2011 Apr; 4(4):801-815. PubMed ID: 28879951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes.
    Bonire JJ; Fricker SP
    J Inorg Biochem; 2001 Jan; 83(2-3):217-21. PubMed ID: 11237262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatin.
    Farrell N
    Cancer Invest; 1993; 11(5):578-89. PubMed ID: 8402226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
    Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
    J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tin(IV) cyanoximates: synthesis, characterization, and cytotoxicity.
    Gerasimchuk N; Maher T; Durham P; Domasevitch KV; Wilking J; Mokhir A
    Inorg Chem; 2007 Sep; 46(18):7268-84. PubMed ID: 17676728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.
    Kelland LR; Jones M; Abel G; Valenti M; Gwynne J; Harrap KR
    Cancer Chemother Pharmacol; 1992; 30(1):43-50. PubMed ID: 1586979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy.
    Huang Y; He Y; Huang Z; Jiang Y; Chu W; Sun X; Huang L; Zhao C
    Nanoscale; 2017 Jul; 9(28):10002-10019. PubMed ID: 28682411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.
    Manzotti C; Pratesi G; Menta E; Di Domenico R; Cavalletti E; Fiebig HH; Kelland LR; Farrell N; Polizzi D; Supino R; Pezzoni G; Zunino F
    Clin Cancer Res; 2000 Jul; 6(7):2626-34. PubMed ID: 10914703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platinum (II)-coordinated Portulaca oleracea polysaccharides as metal-drug based polymers for anticancer study.
    Han Q; Huang L; Wang Y; Sun S; Huang H; Li F; Wang F; Chen L; Zhang H; Wang Y
    Colloids Surf B Biointerfaces; 2021 May; 201():111628. PubMed ID: 33639509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dietary carrot on cytostatic drug activity of cyclophosphamide and its main directly acting metabolite: induction of sister-chromatid exchanges in normal human lymphocytes, Chinese hamster ovary cells, and their DNA repair-deficient cell lines.
    Darroudi F; Targa H; Natarajan AT
    Mutat Res; 1988 Apr; 198(2):327-35. PubMed ID: 3352640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly Organotin Acetates against DNA with Possible Implementation on Human Breast Cancer.
    Latsis GK; Banti CN; Kourkoumelis N; Papatriantafyllopoulou C; Panagiotou N; Tasiopoulos A; Douvalis A; Kalampounias AG; Bakas T; Hadjikakou SK
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status of and future perspectives for platinum antitumor drugs].
    Chikuma M; Sato T; Komeda S
    Yakugaku Zasshi; 2008 Mar; 128(3):307-16. PubMed ID: 18311048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
    Kasparkova J; Farrell N; Brabec V
    J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of organotin-resistant bacteria from boston harbor sediments.
    Pain A; Cooney JJ
    Arch Environ Contam Toxicol; 1998 Oct; 35(3):412-6. PubMed ID: 9732471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair.
    Brabec V
    Prog Nucleic Acid Res Mol Biol; 2002; 71():1-68. PubMed ID: 12102553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents.
    Stefanizzi V; Minutolo A; Valletta E; Carlini M; Cordero FM; Ranzenigo A; Prete SP; Cicero DO; Pitti E; Petrella G; Matteucci C; Marino-Merlo F; Mastino A; Macchi B
    Molecules; 2023 May; 28(9):. PubMed ID: 37175265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.